Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROBE-PSMA: Biomarkers for PSMA-Targeted Radioligand Therapy in Prostate Cancer
jRCT1020260017Recruiting
- Start
- Jun 2026
- Countries
- 1
01
Overview
Open-label trial in prostate cancer (PCa) (2 arms), sponsored by none. Started Jun 2026; status: recruiting.
02
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on jRCT1020260017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1020260017.